{"entity":{"id":"nct06792435","kind":"trial","name":"XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.","aka":[],"tldr":"A phase 1/2 trial of XNW27011 in ovarian cancer and colorectal cancer, run by Astellas Pharma Global Development, Inc., active and no longer recruiting.","summary":"XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. is a phase 1/2 interventional study registered as NCT06792435 by Astellas Pharma Global Development, Inc., with 240 participants planned, started 2023-07-27 and due to reach its primary completion in 2026-12-30. Interventions recorded: XNW27011, XNW27011. Conditions listed: Pancreatic Adenocarcinoma Metastatic, Lung Cancer (NSCLC), Ovarian Cancer, Colorectal Cancer Metastatic. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06792435","url":"https://clinicaltrials.gov/study/NCT06792435"}],"tags":["ctgov-ingest"],"related":[],"cancers":["ovarian","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["xnw27011"],"companies":["astellas"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06792435","phase":"1/2","setting":"A Phase I/Ⅱ, First-in-Human Study of XNW27011 in Patients With Locally Advanced and/or Metastatic Solid Tumors","sponsor":"Astellas Pharma Global Development, Inc.","enrolled":240,"outcomes":[]},"route":"/trials/nct06792435/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"xnw27011","kind":"drug","name":"XNW27011","route":"/drugs/xnw27011/"}],"company":[{"id":"astellas","kind":"company","name":"Astellas","route":"/companies/astellas/"}]}}